NVE Corporation 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2006, and the six months ended on that date. NVE Corporation develops, manufactures, and sells "spintronics" devices, a nanotechnology utilizing electron spin for data acquisition, storage, and transmission. The company also licenses MRAM technology and manufactures high-performance sensors and couplers.
Key Financial Metrics
| Metric | Quarter Ended Sept 30, 2006 | Six Months Ended Sept 30, 2006 |
|---|---|---|
| Total Revenue | $4,398,368 | $8,033,563 |
| Net Income | $1,283,471 | $2,175,277 |
| Diluted EPS | $0.27 | $0.45 |
| Gross Margin | 67.3% | 64.7% |
| Operating Cash Flow (6mo) | $1,877,736 | |
| Cash & Investments | $13,689,311 (as of Sept 30, 2006) | |
| Debt | None (Capital lease obligations retired in June 2006) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 44% for the quarter and 32% for the six months compared to the prior year periods. This was driven by an 87% increase in product sales, partially offset by a 40% decrease in contract research and development revenue due to a strategic shift toward company-funded research.
- Profitability: Net income surged 253% for the quarter and 180% for the six months. Gross profit margins expanded significantly (from 47% to 67% for the quarter) due to a more profitable revenue mix and price increases implemented in calendar 2006.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose 36% for the quarter, primarily due to the adoption of SFAS No. 123(R) regarding stock-based compensation, which added approximately $117,000 in expenses for the quarter.
- Liquidity: Cash and cash equivalents decreased from $1.29 million to $363,268 during the six-month period, while total investments (short and long-term) increased significantly to $13.3 million, reflecting a strategy to deploy operating cash into interest-bearing securities.
Guidance, Outlook, and Risks
- Outlook: Management expects product sales to increase for the remainder of fiscal 2007 due to new coupler and sensor products and growth in the medical device market. However, they anticipate a seasonal dip in the quarter ending December 31, 2006, and expect contract research revenue to continue declining.
- Margin Expectations: Gross profit margins are expected to continue increasing due to manufacturing efficiencies and a continued shift in revenue mix toward higher-margin product sales.
- Legal Contingencies: The company is involved in consolidated class action litigation alleging securities violations regarding projected revenues and technology. NVE believes the claims are without merit and has not recorded a liability, though legal expenses are expected to continue.
- Regulatory Risks: The company anticipates becoming an "Accelerated Filer," requiring compliance with Section 404 of the Sarbanes-Oxley Act, which may incur significant costs and require management evaluation of internal controls.
Investor Verification Checklist
- Verify the sustainability of the 67% gross margin given the shift away from contract research revenue.
- Monitor the status and potential financial impact of the consolidated class action lawsuit filed in February 2006.
- Assess the impact of customer concentration, as the company relies on several large customers whose orders can be canceled or reduced without cause.
- Review the company's ability to meet Section 404 Sarbanes-Oxley compliance requirements as an Accelerated Filer.
- Confirm the timing of the seasonal revenue dip expected in the quarter ending December 31, 2006.